(Q33723762)

28 July 2017

title

Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases (English)

1 reference

28 July 2017

1 reference

Stephanie J Reisinger

1

1 reference

28 July 2017

Patrick B Ryan

2

1 reference

28 July 2017

Donald J O'Hara

3

1 reference

28 July 2017

Gregory E Powell

4

1 reference

28 July 2017

Jeffery L Painter

5

1 reference

28 July 2017

Edward N Pattishall

6

1 reference

28 July 2017

Jonathan A Morris

7

1 reference

28 July 2017

language of work or name

1 reference

1 November 2010

1 reference

Journal of the American Medical Informatics Association

28 July 2017

published in

1 reference

28 July 2017

volume

17

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

652-662

1 reference

Postmarketing safety reports for human drug and biological products; electronic submission requirements. Final rule

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Semi-automated risk estimation using large databases: quinolones and Clostridium difficile associated diarrhea.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Early detection of adverse drug events within population-based health networks: application of sequential testing methods.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Risk of myocardial infarction associated with selective COX-2 inhibitors: meta-analysis of randomised controlled trials.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Perspectives on the use of data mining in pharmaco-vigilance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Benefit-risk assessment of rofecoxib in the treatment of osteoarthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Limitations and strengths of spontaneous reports data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Beyond debacle and debate: developing solutions in drug safety

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

COX-2 inhibitors--lessons in drug safety

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

What is the harm-benefit ratio of Cox-2 inhibitors?

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

30 October 2018

The FDA and Drug Safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3000752

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile

30 October 2018

1 reference

12 December 2020

Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident

1 reference

12 December 2020

Merck withdraws Vioxx; FDA issues public health advisory

1 reference

12 December 2020

The record on rosiglitazone and the risk of myocardial infarction

1 reference

12 December 2020

Evaluating drug effects in the post-Vioxx world: there must be a better way

1 reference

12 December 2020

Drug safety. Gaps in the safety net

1 reference

12 December 2020

10.1136/JAMIA.2009.002477

Identifiers

DOI

1 reference

journals/jamia/ReisingerROPPPM10

28 July 2017

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference

28 July 2017

1 reference